DE:R2WA Stock Latest News
Company AnnouncementsBeximco Pharma Settles With Regulator and Agrees to Reconstituted Board1M ago
Company AnnouncementsBeximco Pharma Clarifies Board Restructuring Reports Amid Ongoing BSEC Dispute1M ago
Company AnnouncementsBeximco Pharma lifts revenue, profit and dividend on surging export sales4M ago
Company AnnouncementsBeximco Pharma posts double-digit revenue and profit growth in Q3 and nine months4M ago
Company AnnouncementsBeximco Pharma Delivers Double-Digit Revenue and Profit Growth in First Half 2025-264M ago
Company AnnouncementsBeximco Pharma lifts Q1 revenue and profit on strong domestic growth4M agoCompany AnnouncementsBeximco Pharma clears 2025 accounts, proposes cash dividend and eyes return to AIM4M ago
Company AnnouncementsBeximco Pharma posts robust profit growth as delayed results clear regulatory hurdle4M ago
Company AnnouncementsBeximco launches cut‑price cystic fibrosis therapy as first patients receive TRIKO4M ago- Company AnnouncementsBeximco Pharma Delays Court Hearing on Dispute Over New Independent Directors8M ago
- Company AnnouncementsBeximco Pharma Challenges Regulator’s Order on Financial Reporting and Board Changes9M ago
Company AnnouncementsBeximco Pharma Faces AIM GDR Trading Suspension Over Delayed Annual Results10M agoCompany AnnouncementsBeximco Pharmaceuticals Seeks Extension for Q1 Financial Results Amid Governance Delays11M ago
- Company AnnouncementsBeximco Pharma Seeks Extension for Financial Results Amid Board Appointment Delays1y ago
Company AnnouncementsBeximco Pharma Launches Affordable Cystic Fibrosis Treatment1y ago
Company AnnouncementsBeximco Pharma Awaits High Court Decision on Board Expansion1y ago
Company AnnouncementsBeximco Pharma Awaits High Court Decision on Board Expansion1y ago
Company AnnouncementsBeximco Pharma Seeks Extension for Q3 Financial Results Amid Board Appointment Delays1y ago